Table 1.
Prevalence, % (95%CI) | N studies | N participants | I2 (95%CI) | H (95%CI) | p heterogeneity | P Egger test | p difference | |
---|---|---|---|---|---|---|---|---|
Overall | 4.7 (4.0–5.4) | 17 | 5629 | 37.9 (0.0–65.2) | 1.3 (1.0–1.7) | 0.058 | 0.076 | – |
By site | ||||||||
ANC | 4.8 (3.8–5.8) | 12 | 3723 | 48.6 (0.0–73.6) | 1.4 (1.0–2.0) | 0.029 | 0.026 | 0.664 |
ANC irrespective | 4.5 (3.5–5.5) | 5 | 1906 | 6.9 (0.0–80.6) | 1.0 (1.0–2.3) | 0.368 | 0.939 | |
By median sample size | ||||||||
< 318 | 5.0 (3.9–6.2) | 8 | 1846 | 22.1 (0.0–64.0) | 1.1 (1.0–1.7) | 0.253 | 0.349 | 0.418 |
≥ 318 | 4.5 (3.6–5.5) | 9 | 3783 | 48.6 (0.0–76.1) | 1.4 (1.0–2.0) | 0.049 | 0.148 | |
By HBV screening tool | ||||||||
ELISA | 5.2 (4.2–6.3) | 9 | 2306 | 18.8 (0.0–60.5) | 1.1 (1.0–1.6) | 0.275 | 0.877 | 0.122 |
Rapid | 4.2 (3.3–5.2) | 8 | 3323 | 41.8 (0.0–74.3) | 1.3 (1.0–2.0) | 0.100 | 0.320 | |
Regions | ||||||||
Central | 4.9 (3.9–6.0) | 5 | 1665 | 0.0 (0.0–74.3) | 1.0 (1.0–2.0) | 0.519 | 0.910 | 0.405 |
Eastern | 6.9 (4.4–10.0) | 1 | 318 | NA | NA | NA | NA | |
North Eastern | 4.9 (3.0–7.3) | 1 | 385 | NA | NA | NA | NA | |
North West | 4.4 (3.1–5.8) | 3 | 911 | 0.0 (0.0–69.8) | 1.0 (1.0–1.8) | 0.708 | 0.534 | |
Northern | 5.5 (3.3–8.2) | 1 | 328 | NA | NA | NA | NA | |
South West | 3.6 (2.4–5.0) | 2 | 782 | 1.0 | 0.0 | 0.928 | NA | |
Southern | 4.8 (2.3–8.0) | 4 | 1240 | 79.7 (46.0–92.3) | 2.2 (1.4–3.6) | 0.002 | 0.198 | |
Methodological quality | ||||||||
JBI ≤ 80 | 4.9 (4.0–5.9) | 11 | 3823 | 48.4 (0.0–74.2) | 1.4 (1.0–2.0) | 0.036 | 0.039 | 0.405 |
JBI > 80 | 4.3 (3.3–5.4) | 6 | 1806 | 15.7 (0.0–78.6) | 1.1 (1.0–2.2) | 0.131 | 0.596 |
CI confidence interval, NA not applicable